UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

 

FORM 8-K

_________________________

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):   January 10, 2017

 

_________________________

 

NEXEON MEDSYSTEMS INC

(Exact Name of Registrant as Specified in Charter)

 

 

Nevada   000-55655   81-0756622
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

 

 

1708 Jaggie Fox Way

Lexington, Kentucky

  40511  
  (Address of Principal Executive Offices)   (Zip Code)  

 

 

844-919-9990

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

_________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

1
 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Acquisition Agreement

 

On January 10, 2017, Rosellini Scientific, LLC, a limited liability company formed under the laws of the State of Texas, (“RS”) and Nexeon Medsystems Europe, S.a.r.l., a Luxembourg private limited liability company (hereinafter referred to as “Nexeon Europe”), which is a wholly-owned subsidiary of Nexeon MedSystems Inc, a Nevada corporation, (the “Company”), and in the presence of Nexeon Medsystems Belgium S.p.r.l., a company incorporated under the laws of Belgium, (hereinafter referred to as “BelCo”), entered into an Acquisition Agreement. RS is the sole shareholder of BelCo owning 107,154 shares (the “Shares”).

 

Pursuant to the Acquisition Agreement, RS is granting to Nexeon Europe the exclusive and irrevocable right to purchase the Shares upon the terms and conditions set forth in the Acquisition Agreement (the “Right to Purchase”). The consideration for the Right to Purchase is US $1,000 (the “Acquisition Price”). Nexeon Europe shall have the right to exercise the Right to Purchase commencing from the date of the Acquisition Agreement and terminating on December 31, 2017 (the “Acquisition Period”). In the event Nexeon Europe exercises the Right to Purchase, the Agreement shall be automatically deemed converted into and considered a share transfer agreement for the purchase of the Shares and the Acquisition Price shall be considered the Purchase Price of the Shares and shall be deemed to have been satisfied by Nexeon Europe to RS as of the date of the Acquisition Agreement. If Nexeon Europe elects not to exercise the Right to Purchase on or before December 31, 2017, then the Acquisition Agreement shall become null and void and of no further force and effect.

 

Pursuant to the terms of the Acquisition Agreement, closing of the transaction is conditioned upon the delivery to Nexeon Europe of a two year audit for years ending December 31, 2015 and 2016 of BelCo, to be completed by April 15, 2017. RS shall be solely responsible and liable for any and all fees, costs and expenses associated with such audit. The audit shall be conducted in compliance with United States GAAP and PCAOB Standards along with any other requirements in conjunction with the financial reporting regulations as issued and applied by the U.S. Securities and Exchange Commission.

 

The foregoing description of the terms of the Acquisition Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the agreement itself, a copy of which is filed as Exhibit 10.1 to this report, and the terms of which are incorporated herein by reference.

 

Description of BelCo

 

Nexeon Medsystems Belgium, S.p.r.l., formerly known as Rosellini Scientific Benelux, is wholly-owned subsidiary of RS and is a medical device manufacturing company with 10 full-time employees and consultants. BelCo was originally formed in 2013 and is located in Liege, Belgium. BelCo has previously received a number of subsidies from the government of the Walloon region in Belgium to develop active implantable medical devices.  In addition, BelCo has acquired assets related to an implantable neurostimulation device system, the Synapse™, for use in the treatment of neurological diseases.   The Synapse™ was previously issued a CE Mark for use in the treatment of certain movement disorders associated with Parkinson's disease.  It also is being manufactured for a number of commercial partners, including Galvani Bioelectronics and John Hopkin's University, for use in their various research projects. 

 

Description of Nexeon Europe

 

Nexeon Europe is a wholly–owned subsidiary of the Company formed on October 28, 2016. The Company and Nexeon Europe are part of the Nexeon group of companies (the “Group”) that is currently being restructured in order to achieve a more efficient and cost-effective Group structure.

 

2
 

 

Loan Agreement and Promissory Note

 

In connection with the Acquisition Agreement described above and based on the contemplation that Nexeon Europe shall acquire all of the shares of BelCo in order for BelCo to become a part of the Nexeon group of companies, Nexeon Europe (Lender) and BelCo (Borrower) entered into a Loan Agreement and related Promissory Note pursuant to which the Nexeon Europe agrees to make a loan to the BelCo in the aggregate principal amount of EUR 1,000,000 (One Million Euros) (the “Loan”). The Loan shall mature on the first Business Day falling one (1) year from the date of the Loan Agreement (the “Maturity Date”). The Maturity Date shall be extended and the term of the Loan Agreement automatically renewed for successive thirty (30) day periods unless the BelCo notifies the Nexeon Europe within ten (10) days of the then upcoming Maturity Date that it intends to repay the full amount or the then outstanding amount of the Loan prior to the upcoming Maturity Date. BelCo may repay, either partially or entirely, the Loan and/or accrued interest thereon at any time prior to the Maturity Date without penalty, upon giving at least two (2) Business Days’ prior written notice to Nexeon Europe. BelCo and Nexeon Europe may also agree to settle the Loan through the inter-company account netting procedure or to capitalize as an investment in the subsidiary.

 

The Loan shall bear interest at the rate of 5% per annum on a 365 day year basis and the actual number of days elapsed. Accrued interest on the unpaid principal amount of the Loan shall be payable on the Maturity Date. Accrued interest on any partial repayment of the Loan shall be payable on the earlier of the date of repayment or the first business day of the month following partial repayment.

 

The foregoing description of the terms of the Loan Agreement and related Promissory Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Loan Agreement and the Promissory Note, copies of which are filed as Exhibits 10.2 and 10.3 to this report, and the terms of which are incorporated herein by reference.

 

Security Agreement

 

In connection with the Acquisition Agreement, the Loan Agreement and the Promissory Note described above, BelCo and Nexeon Europe entered into a Security Agreement pursuant to which BelCo has agreed to grant a security interest in the Collateral (as defined below) as security for the Loan being granted pursuant to the Loan Agreement.

 

As collateral security for the payment in full when due (whether at stated maturity, by acceleration or otherwise) of the Loan, BelCo pledged and granted to Nexeon Europe, as Secured Party for the benefit of the Secured Party, a security interest in all of BelCo’s right, title and interest in, to and under all of its properties, including but not limited to personal and real property, in each case whether tangible or intangible, in whatever format (as applicable), wherever located, and whether now owned by the BelCo or hereafter acquired and whether now existing or hereafter coming into existence (collectively, the “Collateral”).

 

The foregoing description of the terms of the Security Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the agreement itself, a copy of which is filed as Exhibit 10.4 to this report, and the terms of which are incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description
     
10.1   Acquisition Agreement between Rosellini Scientific, LLC and Nexeon Medsystems Europe, S.a.r.l.
10.2   Loan Agreement between Nexeon Medsystems Europe, S.a.r.l. and Nexeon Medsystems Belgium S.p.r.l.
10.3   Promissory Note of Nexeon Medsystems Belgium S.p.r.l.
10.4   Security Agreement between Nexeon Medsystems Europe, S.a.r.l. and Nexeon Medsystems Belgium S.p.r.l.

 

 

3
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEXEON MEDSYSTEMS INC
   
   
  By: /s/ Ronald Conquest
Date:   January 17, 2017   Ronald Conquest
   

Executive Vice President of Corporate Finance

 

4
 

 

EXHIBIT 10.1

 

ACQUISITION AGREEMENT

 

This acquisition agreement (the “ Acquisition Agreement ”) is entered into as of the 10 th day of January 2017 and is effective as of the 2 nd day of January, 2017 (the “ Effective Date ”),

 

BY AND BETWEEN

 

(1) Rosellini Scientific, LLC , a limited liability company formed under the laws of the State of Texas, United States of America, having its registered office at 2820 Lynn Dell Tool, Dallas, Texas 75143, United States of America, registered with the Texas Secretary of State, Division of Corporations under number 46.0827294, represented for the execution of the present agreement by the undersigned person(s) being duly authorized and fully empowered for that purpose (the “ Grantor ”); and

 

(2) Nexeon Medsystems Europe, S.à r.l. ,   a Luxembourg private limited liability company ( société à responsabilité limitée ), having its registered office at 33, rue du Puits Romain, L-8070 Bertrange, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies register under number B 210009, represented for the execution of the present agreement by the undersigned person(s) being duly authorized and fully empowered for that purpose (the “ Grantee ”),

 

AND IN THE PRESENCE OF

 

Nexeon Medsystems Belgium S.p.r.l. , a company incorporated under the laws of Belgium, having its registered office at Rue du Bois St-Jean 15/1 4102 Seraing, Belgium, registered with the Belgian Companies Register (BCE) under number 0525.673.682, represented for the execution of the present agreement by the undersigned person(s) being duly authorized and fully empowered for that purpose (“ BelCo ”).

 

The Grantor and the Grantee are hereafter referred to collectively as the “ Parties ” or individually referred to as a “ Party ”.

 

PREAMBLE

 

WHEREAS the Grantor and the Grantee, which is a wholly-owned subsidiary of Nexeon Medsystems, Inc., a Nevada corporation, are part of the Nexeon group of companies (the “ Group ”) that is currently being restructured in order to achieve a more efficient and cost effective Group structure (the “ Restructuring ”);

 

1
 

 

WHEREAS the Grantor is the sole shareholder owning 107,154 (one hundred seven thousand one hundred fifty-four) shares of Belco having a par value of EUR 1.- (one euro) each in the share capital of BelCo (the “ Shares ”);

 

WHEREAS the Grantor wishes to grant to the Grantee the exclusive and irrevocable right to purchase the Shares upon the terms and conditions set forth herein (the “ Right to Purchase ”), and the Grantee desires to accept the Right to Purchase in consideration for the payment of an amount of USD 1,000 (one thousand United States dollars) (the “ Acquisition Price ”);

 

WHEREAS in view of the Restructuring the Grantee shall have the right to exercise the Right to Purchase at any time during the period commencing as of the date hereof and terminating on 31 December 2017 (the “ Acquisition Period ”); and

 

WHEREAS , in the event the Grantee timely exercises the Right to Purchase, this Acquisition Agreement shall be automatically deemed converted into and considered a share transfer agreement (the “ Share Transfer Agreement ”) for the purchase, by the Grantee from the Grantor, of the Shares, on the terms and conditions herein set forth herein (the “ Share Transfer ”).

 

NOW THEREFORE,

 

IN CONSIDERATION of the mutual agreements herein set forth, and other valuable consideration, receipt of which is hereby acknowledged, the Parties hereby agree as follows:

 

ARTICLE I

GRANT OF RIGHT TO PURCHASE

 

1. In consideration of the payment by Grantee to Grantor of the Acquisition Price, the Grantor hereby grants to the Grantee, and the Grantee hereby accepts, the exclusive and irrevocable Right to Purchase pursuant to the terms, covenants and conditions set forth herein. By signing the present Acquisition Agreement the Grantor hereby acknowledges having received the Acquisition Price.

 

ARTICLE II

TERM AND MANNER OF EXERCISE OF RIGHT TO PURCHASE

 

2.1. The Right to Purchase shall be exercisable by the Grantee at any time during the Acquisition Period upon a two (2) day prior written notice by Grantee to Grantor in accordance with the present Acquisition Agreement and prior to the expiration of the Acquisition Period. Such notice shall be made in writing.

 

2
 

 

2.2. If the Grantee elects to exercise the Right to Purchase, the consummation and closing of the Share Transfer (the “ Closing ”) shall take place at 10:00 a.m. (CET), on a date to be specified by the Parties, which shall not be earlier than two (2) business days (i.e. a day during which banks in Luxembourg are open for general business purposes) following the exercise of such Right to Purchase (the “ Closing Date ”) at the offices of Grantee, unless another date, place or time is agreed to in writing by the Parties hereto.

 

2.3 If the Grantee elects not to exercise the Right to Purchase on or before the last date of the Acquisition Period, the Right to Purchase and this Acquisition Agreement shall be deemed cancelled and terminated and thus be null and void and of no further force and effect. If the Grantee timely and validly exercises the Right to Purchase, this Acquisition Agreement shall automatically become and be deemed a Share Transfer Agreement on the terms and conditions herein set forth. Parties hereby irrevocably undertake, in case of Grantee’s timely exercise of the Right to Purchase, to prepare and sign all such documents and to do whatever is necessary under Belgian law, and any other applicable laws, in order to complete and implement the Share Transfer effective as of the Closing Date.

 

ARTICLE III

ACQUISITION PRICE

 

3.1. In consideration for the Share Transfer, and any and all rights and benefits granted thereunder to the Grantee during the Acquisition Period, the Grantee shall pay to the Grantor by wire transfer of immediately available funds the Acquisition Price; provided, however, that the Grantee will be entitled to deduct and withhold or cause the Grantor to deduct and withhold any withholding taxes or other amounts required under the applicable laws to be deducted and withheld. To the extent that any such amounts are so deducted or withheld, such amounts will be treated for all purposes of this Acquisition Agreement as having been paid to the person or entity in respect of which such deduction and withholding was made.

 

3.2. In the event the Grantee elects to exercise the Right to Purchase, the Acquisition Price will equal to and shall be considered the purchase price of the Shares (the “ Purchase Price ”) and shall be deemed to have been satisfied by Grantee to Grantor as of the date of this Acquisition Agreement.

 

3
 

 

ARTICLE IV

TERMS OF THE SHARES TRANSFER

 

4.1. In the event the Grantee elects to exercise the Right to Purchase, the Grantee shall purchase and acquire from Grantor, and the Grantor shall sell, transfer and convey to Grantee the Shares on the terms set forth in the present section.

 

4.2. The Grantor shall sell, transfer and convey the Shares to Grantee with all its title, rights and interest in and to the Shares, including but not limited to any rights to receive payment(s) thereunder, in exchange for the Purchase Price, all this under the terms and conditions of this Acquisition Agreement.

 

4.3. The Grantee shall purchase and acquire the Shares free and clear from any liens and encumbrances, whether known or unknown to the Grantor, together with all accrued benefits and rights attached thereto, in exchange for the Purchase Price, all this under the terms and conditions of this Acquisition Agreement.

 

4.4. The Grantor and the Grantee agree to and confirm the Purchase Price to be considered paid per the terms and conditions as set forth herein.

 

4.5. The Grantor shall execute and/or deliver all necessary documents and/or instruments of the transfer of the Shares and take all necessary steps and actions in order to make effective the Share Transfer to the Grantee on the Closing Date.

 

4.6. In this respect, the Grantor unconditionally undertakes to cause the Grantee’s ownership of the Shares to be supported and evidenced by executing the relevant documentation and perform any necessary filings and registrations, as the case may be.

 

4.7. The consideration to be paid by the Grantee to the Grantor for the sale, transfer and conveyance of the Shares from Grantor to Grantee shall be equal to the amount of the Purchase Price.

 

4.8 Upon the execution hereof Grantor shall cause to commence the performance of an audit of Belco for the financial years ending December 31, 2015 and ending December 31, 2016, respectively, and to be fully and unconditionally completed by April 15, 2017 at the latest. The Grantor shall be solely responsible and liable for any and all fees, costs and expenses associated with such audit. The audit shall be conducted in compliance with United States GAAP and PCAOB Standards along with any other requirements in conjunction with the financial reporting regulations as issued and applied by the U.S. Securities and Exchange Commission.

 

4
 

 

ARTICLE V

TITLE

 

5. The Grantor agrees that it will not create or cause to create any encumbrance, lien or other matter which would adversely affect or encumber title to the Shares during the term of this Acquisition Agreement and Acquisition Period without first securing the written consent of the Grantee.

 

ARTICLE VI  

 

REPRESENTATIONS AND WARRANTIES OF THE GRANTOR

 

6.1. As an inducement to the Grantee to enter into and perform this Acquisition Agreement, the Grantor hereby represents and warrants to the Grantee as follows:

 

(i)             it is (a) duly organized, validly existing and in good standing under the laws of the State of Texas, and (b) is duly qualified to do business and in good standing in each jurisdiction it is qualified;

(ii)            it has legal right and full power and authority to grant the Right to Purchase as provided for herein and, should the Grantee decide to exercise the Right to Purchase, to agree to and with the Share Transfer;

(iii)          the execution, delivery and performance of the Right to Purchase by the Grantor and the consummation of the transactions contemplated hereby has been duly authorized by all corporate actions required on the part of the Grantor, and does not, and will not, violate any of its constitutional documents or any statutes, laws, orders, regulations, agreements, contracts or similar commitments to which the Grantor or any of its properties is subject;

(iv)           the Shares are in registered form and fully paid and non-assessable;

(v)            the Shares are legally and freely available and unencumbered for the creation of the Right to Purchase in favour of the Grantee and, should the Grantee decide to exercise the Right to Purchase, for the Share Transfer, with all rights and benefits attached thereto, including but not limited to the rights to receive payments thereunder;

(vi)           the Shares subject to the Right to Purchase are owned by the Grantor as the sole legal and beneficial owner thereof, are not subject to any pledge, lien, claim or other encumbrance of any kind, and are not subject to any restriction on transfer or assignment or by any statutes, laws, orders or regulations or any other condition that (a) will or may prevent or impede the creation of the Right to Purchase in favour of the Grantee, or (b) has not been fully disclosed to the Grantee in writing by the Grantor;

 

5
 

 

(vii)         any and all necessary waivers, authorisations, consents and all necessary formalities, as the case may be, have been undertaken and/or obtained in order to allow the Grantor to grant the Right to Purchase; and

(viii)       any and all further formalities, as the case may be, shall be duly carried out by the Grantor in order to duly formalise the Right to Purchase and to render it effective anywhere and towards any third party to the extent this would be required or advisable.

 

ARTICLE VII  

 

REPRESENTATIONS AND WARRANTIES OF THE GRANTEE

 

7.1. As an inducement to the Grantor to enter into and perform this Acquisition Agreement, the Grantee hereby represents, and warrants to the Grantor that:

 

(i)              it is (a) duly organized, validly existing and in good standing under the laws of the Grand Duchy of Luxembourg, and (b) is duly qualified to do business and in good standing in each jurisdiction in which it is qualified;

(ii)            the execution, delivery and performance of this Acquisition Agreement by the Grantee and the consummation of the transactions contemplated hereby has been duly authorized by all corporate actions required on the part of the Grantee, as the case may be, and will not violate its articles of association, statutes, laws, orders, regulations, agreements, contracts and similar commitments to which the Grantee or any of its properties is subject; and

(iii)          it has legal right and full power and authority to execute and deliver, and to exercise its rights and perform its obligations under this Acquisition Agreement;

 

ARTICLE VIII

COMMISSIONS

 

8. The Grantor and the Grantee each hereby represents and warrants to each other that neither of them has dealt with any broker, finder, agent or any other person who might be entitled to a fee in connection with the purchase and sale of the Shares and that no fee or commission is due to any broker, finder, agent or other person in connection with this Acquisition Agreement or the sale and purchase of the Shares contemplated thereby. The Grantor and the Grantee each hereby indemnify the other and agree to hold the other harmless from and against any and all claims, demands, liabilities, losses, judgments, costs and expenses (including, without limitation, reasonable attorneys’ fees) arising directly or indirectly out of any claim for a fee or commission due to any broker, finder, agent or any other person arising out of facts which contravene the warranties herein stated.

 

6
 

 

ARTICLE IX

ASSIGNMENT AND SURVIVAL

 

9.1 Neither the Grantee nor the Grantor may assign this Acquisition Agreement or any of their rights hereunder for any purpose whatsoever without the prior written consent of the other party (which consent shall not be unreasonably withheld by either party) and any purported assignment without such consent shall be absolutely void and of no force and effect.

 

9.2 The respective representations and warranties of each of the contained herein or in any certificate or schedule delivered pursuant hereto shall expire with, and be terminated and extinguished on the Closing Date, and thereafter neither the Grantor nor the Grantee, nor any of their respective affiliates and subsidiaries, shall be under any liability whatsoever with respect to any such representation or warranty.

 

ARTICLE X

MISCELLANEOUS

 

10.1. Entire Agreement . This Acquisition Agreement (including any exhibits and schedules hereto) contains the entire understanding of the Parties hereto with respect to the subject matter hereof, and no prior or contemporaneous written or oral agreement or understanding pertaining to any such matter shall be effective for any purpose. Time is of the essence with regard to this Acquisition Agreement.

 

10.2. Attorneys’ Fees . Should any action be brought arising out of this Acquisition Agreement, including without limitation any action for declaratory or injunctive relief, the prevailing party shall be entitled to payment, reimbursement, settlement or compensation of reasonable attorneys’ fees and costs and expenses incurred in connection with any court case or proceeding under the provision of the present Acquisition Agreement or the relevant applicable law as described in the present Acquisition Agreement, and any judgment or decree rendered in any such actions or proceedings shall include an award thereof.

 

7
 

 

10.3. Binding Effect . The provisions of this Acquisition Agreement shall inure to the benefit of and be binding upon the Grantor and the Grantee and their respective successors and permitted assigns each of which such successors and permitted assigns will be deemed to be a Party hereto for all purposes hereof. Except as expressly provided herein, this Acquisition Agreement is for the sole benefit of the Parties and their permitted successors and assignees and nothing herein expressed or implied will give or be construed to give any person or entity, other than the Parties and such successors and assignees, any legal or equitable rights hereunder.

 

10.4. No Waiver . No waiver of any of the provisions of this Acquisition Agreement shall be deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. No waiver shall be binding unless executed in writing by the party making the waiver. No waiver by any Party of any breach or violation or, default under or inaccuracy in any representation, warranty or covenant hereunder, whether intentional or not, will be deemed to extend to any prior or subsequent breach, violation, default of, or inaccuracy in, any such representation, warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence. No delay or omission on the part of any Party in exercising any right, power or remedy under this Acquisition Agreement will operate as a waiver thereof.

 

10.5. Further Acts . Each party shall, at the request of the other, execute, acknowledge (if appropriate) and deliver whatever additional documents, and do such other acts, as may be reasonably required in order to accomplish the intent and purposes of this Acquisition Agreement.

 

10.6. Counterparts . This Acquisition Agreement may be executed in counterparts, each of which so executed shall be deemed to be an original, and such counterparts shall together constitute but one and the same agreement. This Acquisition Agreement may be executed by facsimile or pdf. signature, which in each such case shall constitute an original for all purposes.

 

10.7. Amendments . This Acquisition Agreement may not be changed or modified except by an instrument in writing executed by the party asserted to be bound thereby.

 

10.8. Notices . All notices, requests, demands, claims and other communications required or permitted to be delivered, given or otherwise provided under this Acquisition Agreement must be in writing and must be delivered, given or otherwise provided:

(a)       by hand (in which case, it will be effective upon delivery);

(b)       by facsimile or electronic mail (in which case, it will be effective upon receipt of confirmation of good transmission); or

8
 

 

(c)       by overnight delivery by a nationally recognized courier service (in which case, it will be effective on the business day after being deposited with such courier service);

in each case, to the address set forth herein above.

 

Each of the Parties to this Acquisition Agreement may specify different address by giving notice in accordance with section 10.8 to each of the other Parties hereto.

 

10.9. Headings . Any headings in this Acquisition Agreement are solely for the convenience of the parties and are not part of this Agreement.

 

10.10. Governing Law and Jurisdiction . This Acquisition Agreement and the transaction(s) herein contemplated shall be construed in accordance with and governed by the laws of the Grand Duchy of Luxembourg. In case of dispute between the Parties the courts of and in Luxembourg will have jurisdiction to settle such dispute unless Parties, by common consent, desire to chose another court.

 

[the remainder of this page is intentionally left blank and signature page is to follow]

 

9
 

 

IN WITNESS WHEREOF , the Grantor and the Grantee have executed this Acquisition Agreement on the day and year first above written in two originals, each Party acknowledging having received its own original.

 

Rosellini Scientific, LLC,
     
     
Signature: /s/ William Rosellini  
Name: William Rosellini  
Title: Manager  

 

 

 

Nexeon Medsystems Europe, S.à r.l. ,  
     
     
Signature: /s/ William Rosellini  
Name: William Rosellini  
Title: CEO  

 

 

AND FOR ACKNOWLEDGMENT PURPOSES:

 

Nexeon Medsystems Belgium S.p.rl.,
     
     
Signature: /s/ William Rosellini  
Name: William Rosellini  
Title: CEO  

 

 

10
 

EXHIBIT 10.2

 

loan agreement

 

This loan agreement (the “ Agreement ”) made as of 10th January 2017 by and between:

 

(i)       Nexeon Medsystems Europe, S.à r.l. ,   a private limited liability company ( société à responsabilité limitée ), having its registered office at 33, rue du Puits Romain, L-8070 Bertrange, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies register under number B 210009 (hereinafter called the “ Lender ”); and

 

(ii)     Nexeon Medsystems Belgium S.p.r.l. , a company incorporated under the laws of Belgium, having its registered office at Rue du Bois St-Jean 15/1 4102 Seraing, Belgium, registered with the Belgian Companies Register under number BE 0525.673.682 (hereinafter called the “ Borrower ”).

 

PREAMBLE

 

WHEREAS pursuant to a certain Acquisition Agreement dated on or about January 10, 2017 by and between the Lender and Borrower, it is contemplated that the Lender acquires or shall acquire all of the shares of the Borrower, and any all rights and benefits thereto, including the right to receive payment(s) thereunder, in order for Borrower to become a part of the Nexeon group of companies (the “ Group ”) whereby said Group is currently being restructured in order to achieve a more efficient and cost effective Group structure (hereinafter referred to as the “ Restructuring ”);

 

WHEREAS , in order to facilitate the Restructuring, the Lender hereby wishes to grant a loan to the Borrower, which loan the Borrower hereby wishes to accept;

 

NOW THEREFORE , for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

SECTION 1.     DEFINITIONS.

 

Unless the context otherwise requires, the terms listed below and used in this Agreement shall have the following meanings:

 

Agreement ” shall mean this Agreement and any amendments, modifications, supplements or extensions hereto;

 

1
 

 

Business Day ” shall mean any day other than Saturday and/or Sunday or a day on which businesses are officially closed in Luxembourg or Belgium;

Closing Date ” shall mean the effective date hereof, being 10th January 2017;

Collateral ” shall mean the collateral as defined in the Security Agreement and all the collateral or similar terms as defined in any other Collateral Document and, to the extent applicable, any other assets pledged or assigned pursuant to any Collateral Document;

Collateral Document ” shall mean the Security Agreement and any and all mortgages, collateral assignments, promissory notes, security agreements, pledge agreements, intellectual property security agreements or other similar agreements or instruments, to the extent applicable, delivered to the Lender pursuant to this Agreement;

Default ” shall mean any of the events specified in Section 5 hereof, whether or not any requirement for the giving of notice or the lapse of time or both or any other condition has been satisfied;

Event of Default ” shall mean any of the events specified in Section 5 hereof, provided that any requirement for the giving of notice or the lapse of time or both has been satisfied;

Loan ” shall mean the loan made hereunder pursuant to Section 2.1 hereof;

Maturity Date ” shall mean the first Business Day falling one (1) year from the date hereof, or the Notification Date, or as such date is extended from time to time pursuant to Section 2.2 hereof;

Notification ” shall mean the written notice pursuant to Section 2.3 hereof;

Notification Date ” shall mean the day on which the Notification pursuant to Section 2.3 has been duly made;

Permitted Liens ” shall mean the permitted liens as defined in the Security Agreement;

Principal Loan Amount ” shall mean the principal amount pursuant to Section 2.1 hereof;

Security Agreement ” shall mean the security agreement dated on or about January 10, 2017, by and between the Lender and the Borrower; and

Taxes ” shall mean the taxes specified in Section 2.4 hereof.

 

Section 2 .     AMOUNT AND TERM OF LOAN

 

Section 2.1       Principal Amount; Disbursement . Subject to the terms and conditions of this Agreement, the Lender agrees to make a loan to the Borrower in the aggregate principal amount of EUR 1,000,000 (One Million Euros) (the “ Loan ”).

 

Section 2.2       Maturity; Term . The Loan shall mature on the Maturity Date; provided , however , that the Maturity Date shall be extended and the term of this Agreement automatically renewed for successive thirty (30) day periods unless the Borrower notifies the Lender within ten (10) days of the then upcoming Maturity Date that it intends to repay the full amount or then outstanding amount of the Loan prior to the then upcoming Maturity Date.

 

2
 

 

Section 2.3       Interest; Repayments. The outstanding and unpaid principal of the Loan shall bear interest at the rate of 5% (Five Percent) per annum on a 365 day year basis and the actual number of days elapsed. Interest shall be payable in the manner specified in Section 2.4 below. The Borrower may apply any amount it then owes or may come to owe to the Lender for the repayment of the Loan. The Borrower may repay, either partially or entirely, the Loan and/or accrued interest thereon at any time prior to the Maturity Date without penalty, upon giving at least two (2) Business Days’ prior written notice to the Lender. Borrower and Lender may also agree to settle the Loan through the inter-company account netting procedure.

 

Section 2.4       Payment of Accrued Interest. Accrued interest on the unpaid principal amount of the Loan shall be payable on the Maturity Date. Accrued interest on any partial repayment of the Loan shall be payable on the earlier of the date of repayment or first Business Day of the month following partial repayment. Any such payment is to be effected by Borrower paying to Lender’s bank account in immediately available funds the amount of the partial repayment and accrued interest; provided, however, that upon any repayment of the Loan in full, accrued interest thereon shall be payable at that time.

 

The Borrower and the Lender may agree to capitalize the total interest accrued at maturity. The Borrower and the Lender may further agree to settle the applicable interest through the inter-company account netting procedure.

 

Section 2.5       Taxes .

(a)        If any taxes, impositions or similar charges (the “ Taxes ”) shall be required by law to be deducted from or in respect of any sum payable hereunder to the Lender, (i) the Borrower shall make such deductions, and (ii) the Borrower shall pay the full amount deducted to the relevant taxing authority in accordance with applicable law. The Borrower shall hold the Lender harmless from any liability with respect to the delay or failure by the Borrower to pay any Taxes.

(b)       Within thirty (30) days after the date of any payment of Taxes withheld by the Borrower in respect of any payment to the Lender, the Borrower will furnish to the Lender the original or a certified copy of a receipt acceptable to the Lender evidencing full and unconditional payment thereof.

 

3
 

 

SECTION 3.     CONDITIONS TO BORROWING

 

The borrowing pursuant to Section 2.1 hereof shall be subject to the fulfillment of the following conditions precedent:

 

(a)        Representations and Warranties; No Default . Any representations and warranties required to be made by the Borrower in connection with this Agreement shall be true and correct as of the Closing Date; the Borrower shall have performed all obligations and agreements and complied with all covenants and conditions required to be performed or complied with by it prior to or on the Closing Date; and no Event of Default shall have occurred and be continuing.

(b)        Collateral Documents . The Security Agreement creates in favor of the Lender, as secured party, a legal, valid and enforceable security interest in the Collateral (as defined in the Security Agreement), the enforceability of which is subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or law. When the Security Agreement (or a short form thereof) in proper form is filed in or with the applicable patent office, if any, the Lender shall have a fully perfected lien on, and security interest in, all right, title and interest of the applicable loan party in the intellectual property Collateral (as defined in the Security Agreement) in which a security interest may be perfected by filing, recording, or registering a security agreement or analogous instrument in the applicable patent office, as applicable, in each case prior and superior in right to any other person or entity to the extent required, subject to Permitted Liens having priority under applicable laws. Each Collateral Document to which any loan party is a party creates for the benefit of the Lender, as secured party, the legal, valid and enforceable first priority security interest which such Collateral Document purports to create (subject to Permitted Liens). Without limiting the foregoing, and to the extent applicable, each Collateral Document governed by Luxembourg law creates in favor of the Lender, as secured party, an effective first priority pledge over the collateral described therein to be subject to the pledge (subject by Permitted Liens), enforceable in accordance with its terms, once perfected in accordance with the terms of such Collateral Document.

(c)        Legal Matters . All other instruments and legal and corporate proceedings in connection with the transactions contemplated by this Agreement shall be satisfactory in form and substance to the Lender and its counsel, and counsel to the Lender shall have received copies of all documents which it may have reasonably required in connection therewith.

(d)        Conflict . Notwithstanding anything to the contrary herein, in the event that any provision of this Agreement is deemed to conflict with the Security Agreement or any of the Collateral Documents, the provisions of this Agreement shall control unless the Lender shall otherwise determine.

 

4
 

 

SECTION 4.     COVENANTS.

 

Existence. Conduct of Business. The Borrower will, and will cause each of its subsidiaries and affiliates to, do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence and the rights, licenses, permits, privileges and franchises material to the conduct of its business; provided that the foregoing shall not prohibit (i) any merger, consolidation, liquidation, dissolution or stock or asset sale, or (ii) the conversion of a subsidiary (other than the Borrower) into a limited liability company, a corporation or other organizational form.

 

Payment of Obligations. The Borrower will, and will cause each of its subsidiaries and affiliates to, pay its obligations, including tax liabilities, that, if not paid, could result in a material adverse effect before the same shall become delinquent or in default, except where (a) the validity or amount thereof is being contested in good faith by appropriate proceedings, (b) such party or such subsidiary or affiliate has set aside on its books adequate reserves with respect thereto in accordance with GAAP and (c) the failure to make payment pending such contest could not reasonably be expected to result in a material adverse effect.

 

Compliance with laws. The Borrower will, and will cause each of its subsidiaries and affiliates to, comply with all laws, rules, regulations and orders of any governmental authority applicable to it or its property, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to result in a material adverse effect.

 

Notices . The Borrower hereby covenants that so long as any indebtedness of the Borrower under this Agreement remains outstanding and unpaid, the Borrower shall, unless otherwise consented to in writing by the Lender, promptly give notice in writing to the Lender of (a) the occurrence of any Default under this Agreement or any other material agreement of the Borrower, and (b) any litigation, proceeding, investigation or dispute which may exist or threatening to occur at any time between the Borrower and any third party which might substantially interfere with the normal business activity of the Borrower or the performance of any obligation under this Agreement.

 

SECTION 5.     EVENTS OF DEFAULT.

 

Upon the occurrence of any of the following:

 

(a)       failure by the Borrower to pay the principal of the Loan when due and payable;

 

5
 

 

(b)       if any representation or warranty made by the Borrower in connection with Section 3(a) hereof or in any certificate, financial or other statement furnished at any time under or in connection with this Agreement shall prove to have been untrue or misleading in any material respect when made;

(c)       default by the Borrower in the observance or performance of any other covenant or agreement contained in this Agreement, and the continuance of the same for thirty (30) days after written notice of such default is given to the Borrower by the Lender;

(d)       if the Borrower shall default in the payment of principal amount any obligation for borrowed money or fail to discharge any final judgment rendered against it having a principal amount in excess of EUR 10,000.- (ten thousand Euros) or the equivalent in any other currency beyond the relevant grace period, if any, with respect thereto;

(e)       (i) the Borrower shall commence any case, proceeding or other action (a) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, liquidation, dissolution, composition or other relief with respect to it or its debts or (b) seeking appointment of a receiver, trustee, custodian or other similar official for it for all or any substantial part of its property, or the Borrower shall make a general assignment for the benefit of its creditors; or (ii) there shall be commenced against the Borrower any case, proceeding or other action of a nature referred to in clause (i) above or seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its property, which case, proceeding or other action (x) results in the entry of an order for relief or (y) remains undismissed, undischarged or unbounded for a period of sixty (60) days; or (iii) the Borrower shall take any action indicating consent to, approval for, or acquiescence in, or in furtherance of, any of the acts set forth in clause (i) or (ii) above; or (iv) the Borrower shall generally not, or shall be unable to, pay its debts as they become due or shall admit in writing its inability to pay its debts; or

(f)       any material adverse change (as reasonably determined by the Lender) shall have occurred in the financial condition of the Borrower;

 

(X) if such event of default (“ Event of Default ”) is an event specified in Section 5(e) above, then the principal amount of the Loan shall be immediately due and payable without notice or demand; and (Y) if such Event of Default is any other event of default specified above, the Lender may declare, by written notice to the Borrower, the Loan then outstanding to become forthwith due and payable, whereupon the principal amount of the Loan shall become immediately due and payable, together with accrued interest thereon and all fees and other obligations of the Borrower accrued hereunder, without presentment, demand, protest or other notice of any kind, all of which are expressly waived, anything contained herein to the contrary notwithstanding.

 

6
 

 

SECTION 6.      REMEDIES.

 

(a) At any time an Event of Default exists or has occurred and is continuing, the Lender shall have all rights and remedies provided in this Agreement, all of which rights and remedies may be exercised without notice to or consent by any loan party, except as such notice or consent is expressly provided for hereunder or required by applicable laws. All rights, remedies and powers granted to the Lender hereunder, under any of the other Collateral Documents r other applicable laws, are cumulative, not exclusive and enforceable, in Lender’s discretion, alternatively, successively, or concurrently on anyone or more occasions, and shall include, without limitation, the right to apply to a court of equity for an injunction to restrain a breach or threatened breach by any loan party of this Agreement or any of the other Collateral Documents.

 

(b) Without limiting the generality of the foregoing, at any time an Event of Default exists or has occurred and is continuing, the Lender may, at its option, upon notice to the Borrower, accelerate the payment of all obligations and demand immediate payment thereof to the Lender.

 

SECTION 7.     INDEMNIFICATION.

 

The Borrower agrees to indemnify the Lender from and against any and all claims, losses and liabilities growing out of or resulting from the occurrence of any Default of this Agreement, including, but not limited to, the costs for the enforcement hereof. The Borrower agrees to pay all reasonable expenses of the Lender, including, without limitation, the fees and expenses of its counsel, incurred in connection with (i) the enforcement of any part of this Agreement, and any waiver or amendment of any provision hereof, (ii) the administration of this Agreement after the occurrence and during the continuance of any Default hereunder, or (iii) the failure by the Borrower to perform or observe any of the provisions of this Agreement.

 

SECTION 8.     MISCELLANEOUS

 

Section 8.1       Election of Remedies; Waivers . No single or partial waiver by the Lender of any Default, Event of Default, right or remedy which it may have shall operate as a waiver of any other Default, Event of Default, right or remedy or of the same Default, Event of Default, right or remedy on a future occasion. The Borrower hereby waives presentment, notice of dishonor and protest and all other notices and demands whatsoever, except as specifically provided in this Agreement.

 

7
 

 

Section 8.2       Amendment . No amendment, modification or waiver of any provision of this Agreement, nor consent to any departure by the Borrower here from, shall in any event be effective unless the same shall be in writing and signed by the Lender and shall otherwise be made in accordance with the provisions hereof, and then such amendment, waiver or consent shall be effective only in the specific instance and the specific purpose for which it is given.

 

Section 8.3       Survival of Agreements . All agreements, representations and warranties made herein and in any certificates delivered and pursuant hereto shall survive the execution and delivery of this Agreement and shall continue in full force and effect until the indebtedness of the Borrower under this Agreement has been paid and satisfied in full.

 

Section 8.4       Successors and Assigns . This Agreement shall be binding upon and inure to the benefit of the Borrower and the Lender and their respective successors and assigns, except that the Borrower may not transfer or assign any of its rights or interests hereunder without the prior written consent of the Lender.

 

Section 8.5       Notices . All notices and other communications given to or made upon any party hereto in connection with this Agreement shall be in writing and shall be deemed to have been given to or made upon the intended party if transmitted by registered mail, facsimile followed by confirmation of delivery, or by express courier, in each case to the addresses set forth on the first page of this Agreement.

 

Section 8.6       Governing Law . This Agreement and the rights and obligations of the Borrower and the Lender hereunder shall be governed and construed and enforced in accordance with the laws of the Grand Duchy of Luxembourg.

 

Section 8.7       Jurisdiction . The parties agree that the competent commercial courts of Liege, Belgium, shall be the exclusive forum for any dispute arising out of or in connection with this Agreement or for the enforcement thereof, and hereby submit to the jurisdiction of those courts.

 

Section 8.8       Captions . The headings of the sections of this Agreement have been inserted solely for convenience of reference and shall not modify, define or limit the express provisions of this Agreement.

 

8
 

 

Section 8.9       Counterparts . This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which, when taken together, shall constitute one and the same instrument.

 

The remainder of this page intentionally left blank

 

9
 

 

IN WITNESS WHEREOF , the Borrower and the Lender have caused this Agreement to be executed and delivered on their behalf as of the date first written above.

 

For and on behalf of:

Nexeon Medsystems Europe, S.à r.l.
     
     
Signature: /s/ Faruk Durusu  
Name: Faruk Durusu  
Title: Class A Manager  
     
     
Signature: /s/ William Rosellini  
Name: William Rosellini  
Title: Class B Manager  
     

 

 

For and on behalf of:

Nexeon Medsystems Belgium S.p.rl. ,
     
     
Signature: /s/ William Rosellini  
Name: William Rosellini  
Title: CEO  

 

10
 

EXHIBIT 10.3

 

PROMISSORY NOTE

 

 

EUR 1,000,000 (One million Euros)   10th January 2017

 

 

FOR VALUE RECEIVED , the undersigned Nexeon Medsystems Belgium S.p.r.l. , a company incorporated under the laws of Belgium, having its registered office at Rue du Bois St-Jean 15/1 4102 Seraing, registered with the Belgian Companies Register (BCE) under number 0525.673.682 (the " Maker "), hereby unconditionally promises to pay to or to the order of Nexeon Medsystems Europe S.à r.l. ,   a Luxembourg private limited liability company ( société à responsabilité limitée ) having its registered office at 33, rue du Puits Romain, L-8070 Bertrange, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies register under number B 210009 (the “ Holder ”), in lawful money the principal sum of EUR 1,000,000 (one million Euros), plus simple interest (“ Interest ”) on the principal thereof from time to time outstanding at the rate of 5% (five percent) per annum (based upon a 365-day year) (the " Interest Rate ") from the date hereof until such principal is fully paid and satisfied pursuant to the terms and conditions of the loan agreement by and between the Holder, as lender, and Maker, as borrower, dated on or about January 10, 2017 (the “ Loan Agreement ”) as secured by that certain Security Agreement between the Holder, as secured party, and Maker, as grantor, dated on or about January 10, 2017 (the “ Security Agreement ”). Payments under this promissory note (the “ Note ”) shall be made by wire transfer to a bank account designated in writing by the Holder, or in such other manner as the parties shall mutually agree.

 

  1. Principal and Interest . Principal and Interest shall be due and payable as follows: Interest shall be due and payable on the Maturity Date. The interest rate will be set at the execution of this Note and reset quarterly thereafter beginning on April 1, 2017. If any payment of principal or interest falls on a Saturday, Sunday or legal holiday in the jurisdiction of the Holder, such payment shall be made on the next business day. The principal amount of this Note and all accrued and unpaid Interest shall be due and payable on December 31, 2017 (“ Maturity Date ”).

 

  2. Events of Default . If Maker fails timely to make payment of any amount due hereunder and shall not cure such failure within twenty (20) calendar days after written notice from Holder (such failure constituting an “ Event of Default ”), then at the option of Holder, the entire principal balance hereof, all accrued and unpaid Interest and all other applicable fees, costs and charges, if any, shall at once become due and payable, and Maker hereby waives any rights of exemption and waives presentment, protest and demand and notice of protest, demand or dishonor and nonpayment of this Note, and consents that Holder shall have the right without notice to grant any extension or extensions of time for payment of this Note or any part hereof or any other indulgences or forbearances whatsoever, or may release any security which may have been given for this Note without in any way affecting the liability of any other party for the payment of this Note. Furthermore, upon an Event of Default, Holder may exercise any rights or remedy which it has available at law or in equity or by statute, and all of Holder’s rights and remedies shall be cumulative and concurrent, and may be pursued singly, successively or together at the sole discretion of Holder, and same may be exercised as often as occasion therefore shall occur. The failure to exercise any such right or remedy shall not be construed as a waiver or release thereof. Nothing herein contained shall be construed as limiting Holder to the remedies set forth herein.

 

1
 

 

  3. Severability . In the event any one or more of the provisions contained in this Note shall for any reason be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision of this Note, but this Note shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein or therein.

 

  4. Modifications and Amendments . This Note may not be changed orally, but only by an agreement in writing signed by the parties against whom enforcement of any waiver, change, modification or discharge is sought.

 

  5. Collection Fees . In the event Holder incurs any costs or expenses, and including reasonable attorney’s fees, in collecting any amount due under this Note, Maker agrees to pay all such amounts to Holder’s order upon demand.

 

  6. No Offset, Deduction or Counter Claim . The due payment and performance of Maker’s obligations hereunder shall be without regard to any counter claim, right of set-off, or any other deduction whatsoever which Maker may have or assert against Holder and without regard to any other obligations of any nature whatsoever which Holder may have to Maker, and no such claim, right or deduction shall be asserted by Maker in any action for payment and performance of Maker’s obligations hereunder. If Maker is compelled by law or otherwise to make any such deduction then Maker shall pay such additional amount as will result in the receipt by Holder of the full amount due hereunder.

 

2
 

 

  7. Maker’s Power and Authority . Maker warrants and represents that it has full power and authority, and the legal right, to execute, deliver and perform this Note and that this Note constitute valid and binding obligations of Maker.

 

  8. Governing Law; Binding Effect . This Note, and any non-contractual obligations arising out of or connection with it, shall be governed by and construed in accordance with the laws of the Grand Duchy of Luxembourg and shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs, executors, administrators, personal representatives, successors and assigns.

 

  9. Assignment . This Note may be assigned by the Holder without consent of, but with notice to, the Maker.

 

  10. Prepayment. This Note may be prepaid by Maker at any time, or in part from time to time, without penalty, by payment of principal and Interest accrued thereon. Any partial prepayment is to be first credited to accrued Interest and then to the instalment of principal last to mature.

 

* * * Signature Page Follows * * *

 

 

3
 

 

 

IN WITNESS WHEREOF , the Maker has caused this Note to be duly executed on the date first above written.

 

Nexeon Medsystems Belgium S.p.rl.,
     
     
Signature: /s/ William Rosellini  
Name: William Rosellini  
Title: CEO  

 

 

4
 

 

EXHIBIT 10.4

 

 

 

Security AGREEMENT

dated as of

JANUARY 10, 2017

by and between

Nexeon Medsystems Belgium S.p.r.l

as Borrower and Grantor

and

NEXEON MEDSYSTEMS EUROPE, S. À R.L.
as Lender and Secured Party

 

 

1
 

 

Section 1.   Definitions, Etc 2
       
Section 2.   Representations and Warranties 5
       
2.01 Organizational Matters; Enforceability, Etc 6
       
2.02 Title 6
       
2.03 Names, Etc 6
       
2.04 Changes in Circumstances 6
       
2.05 Promissory Notes 7
       
2.06 Intellectual Property  7
       
2.08 Deposit Accounts and Securities Accounts 7
       
Section 3.   Collateral 7
       
3.01 Granting Clause 7
       
Section 4.   Further Assurances; Remedies 8
       
4.01 Delivery and Other Perfection 8
       
4.02 Other Statements and Instruments 9
     
4.03 Preservations of Rights 10
       
4.04 Special Provisions Relating to Certain Collateral 10
       
4.05 Remedies 11
       
4.06 Deficiency 12
       
4.07 Locations; Names, Etc 12
       
4.08 Private Sale 13
       
4.09 Application of Proceeds 13
       
4.10 Attorney in Fact 13
       
4.11 Perfection and Recordation 14
       
4.12 Termination 14
       
4.13 Further Assurances 14
       
Section 5.   Miscellaneous 14
       
5.01 Notices 14
       
5.02 No Waiver 15
       
5.03 Amendments, Etc 15
       
5.04 Expenses 15

 

i
 

 

  5.05 Successors and Assigns 15
       
  5.06 Counterparts 15
       
5.07 Governing Law; Submission to Jurisdiction; Etc 16
       
5.08 Captions 16
       
5.09 Agents and Attorneys in Fact 16
       
5.10 Severability 16

 

ii
 

 

SECURITY AGREEMENT

 

 

SECURITY AGREEMENT (the “ Agreement’ ) dated as of January 10, 2017, among Nexeon Medsystems Belgium S.p.r.l. , a company incorporated under the laws of Belgium, having its registered office at Rue du Bois St-Jean 15/1 4102 Seraing, Belgium, registered with the Belgian Companies Register under number BE 0525.673.682 (“ Borrower ”, or “ Grantor ”), and Nexeon Medsystems Europe, S.à r.l. ,   a private limited liability company ( société à responsabilité limitée ), having its registered office at 33, rue du Puits Romain, L-8070 Bertrange, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies register under number B 210009 (“ Lender ”, or “ Secured Party ”).

 

The Lender has agreed to provide a term loan to Borrower as provided in the Loan Agreement (as defined below).

 

The Grantor has guaranteed its obligations as Borrower to the Lender, as Secured Party, under the Loan Agreement.

 

To induce the Lender to extend credit under the Loan Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor has agreed to grant a security interest in the Collateral (as defined below) of such Grantor as security for the Secured Obligations (as defined below).

 

Accordingly, the Parties hereto agree as follows:

 

Section 1.             Definitions, Etc .

 

Collateral ” has the meaning assigned to such term in Section 3.01 .

 

Copyrights ” means all copyrights, copyright registrations and applications for copyright registrations, including all renewals and extensions thereof, all rights to recover for past, present or future infringements thereof and all other rights whatsoever accruing there under or pertaining thereto.

 

Governmental Authority ” means any nation, government, branch of power (whether executive, legislative or judicial), state, province or municipality or other political subdivision thereof and any entity exercising executive, legislative, judicial, monetary, regulatory or administrative functions of or pertaining to government, including without limitation regulatory authorities, governmental departments, agencies, commissions, bureaus, officials, ministers, courts, bodies, boards, tribunals and dispute settlement panels, and other law-, rule- or regulation-making organizations or entities of any country, city or town of [Belgium] [Luxembourg].

 

Intellectual Property ” means all Patents, Trademarks, Copyrights, and Technical Information, whether registered or not, domestic and foreign. Intellectual Property shall include all:

 

2
 

 

(a)            Applications or registrations relating to such Intellectual Property;

 

(b)            Rights and privileges arising under applicable laws with respect to such Intellectual Property; and

 

(c)             Rights of the same or similar effect or nature in any jurisdiction corresponding to such Intellectual Property throughout the world.

 

Lien ” means any mortgage, lien, pledge, charge or other security interest, or any lease, title retention agreement, mortgage, restriction, easement, right-of-way, option or adverse claim (of ownership or possession) or other encumbrance of any kind or character whatsoever or any preferential arrangement that has the practical effect of creating a security interest.

 

Loan Agreement ” means that certain term loan agreement, dated as of the date hereof, among Borrower and the Lender from time to time party thereto as such agreement is amended, supplemented, or otherwise modified, restated, extended, renewed, or replaced from time to time.

 

Loan Documents ” means, collectively, this Agreement, the Loan Agreement, the Promissory Note and any other present or future document, instrument, agreement or certificate executed by the Grantor and delivered to the Secured Party in connection with or pursuant to this Agreement or any of the other Loan Documents, all as amended, restated, supplemented or otherwise modified.

 

Obligations ” means, with respect to any obligor, all amounts, obligations, liabilities, covenants and duties of every type and description owing by such obligor to the Lender, any other indemnitee hereunder or any participant, arising out of, under, or in connection with, any Loan Document, whether direct or indirect (regardless of whether acquired by assignment), absolute or contingent, due or to become due, whether liquidated or not, now existing or hereafter arising and however acquired, and whether or not evidenced by any instrument or for the payment of money, including, without duplication, (a) if such obligor is Borrower, all Loans, (b) all interest, whether or not accruing after the filing of any petition in bankruptcy or after the commencement of any insolvency, reorganization or similar proceeding, and whether or not a claim for post-filing or post-petition interest is allowed in any such proceeding, and (c) all other fees, expenses (including fees, charges and disbursement of counsel), interest, commissions, charges, costs, disbursements, indemnities and reimbursement of amounts paid and other sums chargeable to such obligor under any Loan Document.

 

Patents ” means all patents and patent applications, including the inventions and improvements described and claimed therein together with the reissues, divisions, continuations, renewals, extensions and continuations in part thereof, all income, royalties, damages and payments now or hereafter due and/or payable with respect thereto, all damages and payments for past or future infringements thereof and rights to sue therefore, and all rights corresponding thereto throughout the world.

 

Permitted Lien ” means any of the following:

 

(a) Liens securing the Obligations;
     

3
 

 

 

(b) any Lien on any property or asset of any parent or any of its Subsidiaries existing on the date hereof; provided that (i) no such Lien shall extend to any other property or asset of such parent or any of its Subsidiaries and (ii) any such Lien shall secure only those obligations which it secures on the date hereof and extensions, renewals and replacements thereof that do not increase the outstanding principal amount thereof;
     
(c) Liens imposed by law which were incurred in the ordinary course of business, including (but not limited to) carriers’, warehousemen’s and mechanics’ liens and other similar liens arising in the ordinary course of business and which (x) do not in the aggregate materially detract from the value of the property subject thereto or materially impair the use thereof in the operations of the business of such Person or (y) are being contested in good faith by appropriate proceedings, which proceedings have the effect of preventing the forfeiture or sale of the property subject to such liens and for which adequate reserves have been made if required in accordance with US GAAP;
     
(d) pledges or deposits made in the ordinary course of business in connection with workers’ compensation, unemployment insurance or other similar social security legislation;
     
(e) Liens securing Taxes, assessments and other governmental charges, the payment of which is not yet due or is being contested in good faith by appropriate proceedings promptly initiated and diligently conducted and for which such reserve or other appropriate provisions, if any, as shall be required by US GAAP shall have been made;
     
(f) servitudes, easements, rights of way, restrictions and other similar encumbrances on real property imposed by applicable laws and encumbrances consisting of zoning or building restrictions, easements, licenses, restrictions on the use of property or minor imperfections in title thereto which, in the aggregate, are not material, and which do not in any case materially detract from the value of the property subject thereto or interfere with the ordinary conduct of the business of any of the parties;
     
(g) with respect to any real property, (A) such defects or encroachments as might be revealed by an up-to-date survey of such real property; (B) the reservations, limitations, provisos and conditions expressed in the original grant, deed or patent of such property by the original owner of such real property pursuant to applicable laws; and (C) rights of expropriation, access or user or any similar right conferred or reserved by or in applicable laws, which, in the aggregate for (A), (B) and (C), are not material, and which do not in any case materially detract from the value of the property subject thereto or interfere with the ordinary conduct of the business of any of the Parties;
     
(h) bankers liens, rights of setoff and similar Liens incurred on deposits made in the ordinary course of business;
     

4
 

 

 

(i) deposits or pledges to secure bids, tenders, contracts (other than contracts for the payment of money), leases, statutory obligations, surety and appeal bonds and other obligations of like nature arising in the ordinary course of business; and
     
(j) Liens arising by virtue of the rendition, entry or issuance against any obligor or any Subsidiary, or any property of any obligor or any Subsidiary, of any judgment, writ, order, or decree to the extent the rendition, entry, issuance or continued existence of such judgment, writ, order or decree (or any event or circumstance relating thereto) has not resulted in the occurrence of an Event of Default hereunder so long as such judgment, writ, order or decree has been stayed pending appeal or the time for payment thereof has not expired;

 

provided that no Lien otherwise permitted under any of the foregoing (a) through (j) shall apply to any Material Intellectual Property.

 

Person ” means any individual, corporation, company, voluntary association, partnership, limited liability company, joint venture, trust, unincorporated organization or Governmental Authority or other entity of whatever nature.

 

Promissory Note ” means the promissory note entered into between Grantor and Lender dated on or about January 10, 2017.

 

Secured Obligations ” means the Obligations of the Grantor.

 

Secured Parties ” means the Lender, the Secured Party and any other holder of any Obligation.

 

Technical Information ” means all trade secrets and other proprietary or confidential information, public information, non-proprietary know-how, any information of a scientific, technical, or business nature in any form or medium, standards and specifications, conceptions, ideas, innovations, discoveries, invention disclosures, all documented research, developmental, demonstration or engineering work and all other information, data, plans, specifications, reports, summaries, experimental data, manuals, models, samples, know-how, technical information, systems, methodologies, computer programs, information technology and any other information.

 

Trademarks ” means all trade names, trademarks and service marks, logos, trademark and service mark registrations, and applications for trademark and service mark registrations, including all renewals of trademark and service mark registrations, all rights to recover for all past, present and future infringements thereof and all rights to sue therefore, and all rights corresponding thereto throughout the world, together, in each case, with the product lines and goodwill of the business connected with the use thereof.

 

1.01         Other Defined Terms . All other capitalized terms used and not defined herein have the meanings ascribed to them in the Loan Agreement.

 

Section 2.             Representations and Warranties . The Grantor represents and warrants to the Lender, as Secured Party, that:

 

5
 

 

2.01         Organizational Matters; Enforceability, Etc . (a) The Grantor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization. The execution, delivery and performance of this Agreement, and the granting of the security interests pursuant hereto, (i) are within the Grantor’s powers and have been duly authorized by all necessary corporate or other action, (ii) do not require any consent or approval of, registration or filing with, or any other action by, any governmental authority or court, except for (A) such as have been obtained or made and are in full force and effect and (B) filings and recordings in respect of the security interests created pursuant hereto, (iii) will not violate any applicable law or regulation or the charter, bylaws, articles of association or other organizational documents of the Grantor or any order of any governmental authority or court binding upon the Grantor or its property, (iv) will not violate or result in a default under any indenture, agreement or other instrument binding upon the Grantor or any of its assets, or give rise to a right there under to require any payment to be made by any such person, and (v) except for the security interests created pursuant hereto, will not result in the creation or imposition of any Lien on any asset of the Grantor.

 

(b)            This Agreement has been duly executed and delivered by the Grantor and constitutes, a legal, valid and binding obligation of the Grantor, enforceable against the Grantor in accordance with its terms, except as such enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or similar laws of general applicability affecting the enforcement of creditors’ rights and (ii) the application of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).

 

2.02         Title . (a) The Grantor is the sole beneficial owner of the Collateral in which it purports to grant a lien hereunder, and no lien exists upon such Collateral (and no right or option to acquire the same exists in favor of any other Person) other than Permitted Liens.

 

(b)            The security interest created or provided for herein constitutes a valid first-priority (subject to Permitted Liens) perfected lien on such Collateral, subject, for the following Collateral, to the occurrence of the following: (i) in the case of Collateral in which a security interest may be perfected by filing a (financing) statement or like instrument naming such Grantor as debtor, the Secured Party as secured party, and listing all personal property as collateral, (ii) with respect to any deposit account, or securities account, the execution of agreements among such Grantor, the applicable financial institution and the Secured Party, effective to grant control over such deposit account, or securities account to the Secured Party, and (iii) with respect to any Intellectual Property not described in the foregoing clause (i) , the filing of this Security Agreement or a short-form security agreement with the applicable Intellectual Property office of the applicable government in the applicable jurisdiction.

 

2.03         Names, Etc . The full and correct legal name, type of organization, jurisdiction of organization, and address of the Grantor as of the date hereof are correctly set forth in the pre-amble hereof.

 

2.04         Changes in Circumstances . The Grantor has not (a) within the period of two (2) months prior to the date hereof, changed its location, or (b) changed its name.

 

6
 

 

2.05         Promissory Notes . Any and all Promissory Notes are held by the Grantor on the date hereof.

 

2.06         Intellectual Property . All of the following are held and owned by the Grantor on the date hereof: (i) applied for or registered Copyrights, (ii) applied for or registered Patents, including the jurisdiction and patent number, (iii) applied for or registered Trademarks, including the jurisdiction, trademark application or registration number and the application or registration date, and (iv) trade names.

 

(a)             Except pursuant to licenses and other user agreements entered into by the Grantor in the ordinary course of business, the Grantor has done nothing to authorize or enable any other Person to use any Copyright, Patent or Trademark and all registrations are in full force and effect.

 

(b)            The Grantor owns and possesses the right to use all Copyrights, Patents and Trademarks. To the Grantor’s knowledge, (i) there is no violation by others of any right of the Grantor with respect to any Copyright, Patent or Trademark, and (ii) the Grantor is not infringing in any respect upon any Copyright, Patent or Trademark of any other Person. No proceedings alleging such infringement have been instituted or are pending against the Grantor and no written claim against the Grantor has been received by the Grantor, alleging any such violation,.

 

2.07         Deposit Accounts and Securities Accounts . The Grantor is the owner and holder of all deposit accounts and securities accounts on the date hereof.

 

Section 3.             Collateral .

 

3.01         Granting Clause . As collateral security for the payment in full when due (whether at stated maturity, by acceleration or otherwise) of the Secured Obligations, the Grantor hereby pledges and grants to Lender, as Secured Party for the benefit of the Secured Party, a security interest in all of the Grantor’s right, title and interest in, to and under all of its properties, including but not limited to personal and real property, in each case whether tangible or intangible, in whatever format (as applicable), wherever located, and whether now owned by the Grantor or hereafter acquired and whether now existing or hereafter coming into existence including without limitation all of the following (collectively, and subject to the proviso at the end of this Section 3.01 (the “ Collateral ”):

 

(a)             all bank accounts, security accounts and similar accounts;

 

(b)            all chattel paper;

 

(c)             all checks;

 

(d)            all deposit accounts;

 

(e)             all documents, books, files, papers and other records;

 

(f)             all encumbrances;

 

7
 

 

(g)            all equipment, whether fixed or movable;

 

(h)            all fixtures and semi-fixtures;

 

(i)             all general intangibles (including without limitation all agreements of any kind);

 

(j)             all goods and properties, personal and real, not otherwise described in this Section 3 ;

 

(k)            all instruments of whatever nature, including all Promissory Notes;

 

(l)             all Intellectual Property;

 

(m)           all inventory;

 

(n)            all letters of credit and all supporting obligations; and

 

(o)           all proceeds of any of the foregoing, all accessions to and substitutions and replacements for, any of the Collateral, and all offspring, rents, profits and products of any of the Collateral, and, to the extent related to any Collateral, all books, correspondence, credit files, records, invoices and other papers (including all tapes, cards, computer runs and other papers and documents in the possession or under the control of such Grantor or any computer bureau or service company from time to time acting for such Grantor).

 

Section 4.             Further Assurances; Remedies . In furtherance of the granting of the security interest pursuant to Section 3 , the Grantor hereby agree with the Secured Party as follows:

 

4.01         Delivery and Other Perfection . The Grantor shall promptly from time to time give, execute, deliver, file, record, authorize or obtain all such (financing) statements, continuation statements, notices, instruments, documents, agreements or consents or other papers as may be necessary or desirable in the judgment of the Lender to create, preserve, perfect, maintain the perfection of or validate the security interest granted pursuant hereto or to enable the Lender, as the Secured Party, to exercise and enforce its rights hereunder with respect to such security interest, and without limiting the foregoing, shall:

 

(a)             promptly from time to time deliver to the Lender any and all instruments constituting part of the Collateral, endorsed and/or accompanied by such instruments of assignment and transfer in such form and substance as the Lender may request; provided that until the occurrence of an Event of Default that has not been waived in writing by the Lender in accordance with the Loan Agreement, the Grantor may retain for collection in the ordinary course any instruments received by the Grantor in the ordinary course of business and the Lender shall, promptly upon request of the Grantor, make appropriate arrangements for making any instrument delivered by the Grantor available to the Grantor for purposes of presentation, collection or renewal (any such arrangement to be effected, to the extent requested by the Lender, against trust receipt or like document);

 

8
 

 

(b)           (i)     promptly from time to time enter into such control agreements, each in form and substance acceptable to the Lender, as may be required to perfect the security interest created hereby in any and all deposit accounts, electronic chattel paper and letter of credit rights, and will promptly furnish to the Secured Party true copies thereof;

 

(i)              (A) in the case of account debtors that make payments to such Grantor directly into an account, ensure that all such account debtors are instructed to make such payments into a deposit account, and (B) deposit all checks received directly by such Grantor from account debtors into an account over which the Secured Party has control;

 

(c)             promptly from time to time upon the request of the Lender, (i) execute and deliver such short-form security agreements as the Lender may deem necessary or desirable to protect the interests of the Secured Party in respect of that portion of the Collateral consisting of Intellectual Property, and (ii) take such other action as the Lender may deem necessary or appropriate duly to record or otherwise perfect the security interest created hereunder in that portion of the Collateral consisting of Intellectual Property registered or located outside of the United States;

 

(d)            to the extent applicable, keep full and accurate books and records relating to the Collateral, and stamp or otherwise mark such books and records in such manner as the Lender may require in order to reflect the security interests granted by this Agreement; and

 

(e)             permit representatives of the Secured Party, upon reasonable notice, at any time during normal business hours to inspect and make abstracts from its books and records pertaining to the Collateral, and permit representatives of the Secured Party to be present at such Grantor’s place of business to receive copies of communications and remittances relating to the Collateral, and forward copies of any notices or communications received by the Grantor with respect to the Collateral, all in such manner as the Lender may require.

 

(f)             (i) promptly from time to time upon the request of the Lender, use commercially reasonable efforts to execute and deliver such real property security documents, landlord consents and collateral access agreements with respect to real property owned or leased (as tenant) by such Grantor wherever located, (ii) obtain a bailee waiver or other agreement from the lessor of each leased property, the mortgagor of owned property or bailee or consignee with respect to any warehouse, processor, converted facility or other location where Collateral in excess of Euro 10,000 is stored or located at such individual location and (iii) cause to be recorded in the appropriate real property records such documents delivered pursuant to this Section 4.01(f) as the Secured Party may deem necessary or appropriate.

 

4.02         Other Statements and Instruments . Except as otherwise permitted under the Loan Documents, the Grantor shall not (a) file or suffer to be on file, or authorize or permit to be filed or to be on file, in any jurisdiction, any (financing) statement or like instrument with respect to any of the Collateral in which the Secured Party is not named as the sole secured party (except to the extent that such (financing) statement or instrument relates to a Permitted Lien), or (b) cause or permit any Person other than the Secured Party to have control of any deposit account, securities account, electronic chattel paper, or letter of credit right constituting part of the Collateral.

 

9
 

 

4.03         Preservation of Rights . The Secured Party shall not be required to take steps necessary to preserve any rights against prior parties to any of the Collateral.

 

4.04         Special Provisions Relating to Certain Collateral .

 

(a)             Intellectual Property . (i) For the purpose of enabling the Secured Party to exercise rights and remedies under Section 4.05 at such time as the Secured Party shall be lawfully entitled to exercise such rights and remedies, and for no other purpose, the Grantor hereby grants to the Lender, to the extent assignable, an irrevocable, non-exclusive license (exercisable without payment of royalty or other compensation to the Grantor) to use, and the right to assign, license or sublicense, any of the Intellectual Property now owned or hereafter acquired by the Grantor, wherever the same may be located, including in such license reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer programs used for the compilation or printout thereof.

 

(ii)            Notwithstanding anything contained herein to the contrary, but subject to any provision of the Loan Documents that limits the rights of the Grantor to dispose of its property, until the occurrence of an Event of Default that has not been waived in writing by the Lender in accordance with the Loan Agreement, the Grantor will be permitted to exploit, use, enjoy, protect, defend, enforce, license, sublicense, assign, sell, dispose of or take other actions with respect to the Intellectual Property in the ordinary course of the business of the Grantor. In furtherance of the foregoing, until the occurrence of an Event of Default that has not been waived in writing by the Lender in accordance with the Loan Agreement, the Secured Party shall from time to time, upon request of the Grantor, execute and deliver any instruments, certificates or other documents, in the form so requested, that the Grantor shall have certified are appropriate in its judgment to allow it to take any action permitted above (including relinquishment of the license provided pursuant to Section 4.04(a)(i) as to any specific Intellectual Property). Further, upon the payment in full of all of the Secured Obligations (other than contingent indemnification obligations for which no claim has been made) or earlier expiration of this Agreement or release of the Collateral, the Lender shall grant back to the Grantor the license granted pursuant to Section 4.04(a)(i) . The exercise of rights and remedies under Section 4.05 by the Secured Party shall not terminate the rights of the holders of any licenses, covenants not to sue or sublicenses theretofore granted by the Grantor in accordance with the first sentence of this Section 4.04(a)(ii) .

 

(b)            Chattel Paper . The Grantor will (i) deliver to the Secured Party each original of each item of chattel paper at any time constituting part of the Collateral, and (ii) cause each such original and each copy thereof to bear a conspicuous legend, in form and substance satisfactory to the Secured Party, indicating that such chattel paper is subject to the security interest granted hereby and that purchase of such chattel paper by a Person other than the Secured Party without the consent of the Secured Party would violate the rights of the Secured Party.

 

10
 

 

(c)             Agreements . The Grantor shall ensure that each Material Agreement entered into after the date hereof (A) may be collaterally assigned to secure the Secured Obligations, (B) may, in the event of any exercise of remedies hereunder, be assigned to a purchaser in a foreclosure sale or equivalent thereof of all or any portion of the Collateral (subject to assumption by such purchaser of all obligations under such Material Agreement), (C) does not contain any provision which restricts or penalizes the granting of a security interest in such Material Agreement or the assignment of such Material Agreement upon the sale or other disposition of all or a portion of a product to which such Material Agreement relates, and (D) permits the disclosure of all information to be provided there under to the Lender, to any assignee or prospective assignee described in the foregoing clause (B) , to any assignee or prospective assignee of the Lender, and to any company in the business of purchasing or financing financial assets. The provisions described in the preceding sentence need not be included directly in such Material Agreement, but may be agreed by the applicable Material Agreement counterparty in a separate letter agreement.

 

4.05         Remedies . (a) Rights and Remedies Generally upon Event of Default . Upon the occurrence of an Event of Default that has not been waived in writing by the Lender in accordance with the Loan Agreement, the Secured Party shall have all of the rights and remedies with respect to the Collateral of a secured party under the applicable laws of the jurisdiction to which the Collateral is subject and such additional rights and remedies to which the Lender is entitled under the laws in effect in any other jurisdiction where any rights and remedies hereunder may be asserted, including the right, to the fullest extent permitted by law, to exercise all voting, consensual and other powers of ownership pertaining to the Collateral as if the Secured Party, was the sole and absolute owner thereof (and the Grantor agrees to take all such action as may be appropriate to give effect to such right). Upon the occurrence of an Event of Default that has not been waived in writing by the Lender in accordance with the terms of the Loan Agreement, the Lender may exercise such rights and remedies described above; and without limiting the foregoing:

 

(i)              the Lender may demand, sue for, collect or receive any money or other property at any time payable or receivable on account of or in exchange for any of the Collateral, but shall be under no obligation to do so;

 

(ii)            the Lender may make any reasonable compromise or settlement deemed desirable with respect to any of the Collateral and may extend the time of payment, arrange for payment in installments, or otherwise modify the terms of, any of the Collateral;

 

(iii)          the Secured Party may require the Grantor to notify (and the Grantor hereby authorizes the Secured Party to so notify) each account debtor in respect of any account, chattel paper or general intangible, and each obligor on any instrument, constituting part of the Collateral that such Collateral has been assigned to the Secured Party hereunder, and to instruct that any payments due or to become due in respect of such Collateral shall be made directly to the Secured Party or as it may direct (and if any such payments, or any other proceeds of Collateral, are received by the Grantor they shall be held in trust by such Grantor for the benefit of the Secured Party and as promptly as possible remitted or delivered to the Secured Party for application as provided herein);

 

(iv)           the Secured Party may require the Grantor to assemble the Collateral at such place or places, convenient to the Secured Party, as the Secured Party may direct;

 

11
 

 

(v)            the Secured Party may sell, lease, assign or otherwise dispose of all or any part of the Collateral, at such place or places as the Secured Party deems best, and for cash or for credit or for future delivery (without thereby assuming any credit risk), at public or private sale, without demand of performance or notice of intention to effect any such disposition or of the time or place thereof (except such notice as is required by applicable statute and cannot be waived), and the Secured Party, or anyone else may be the purchaser, lessee, assignee or recipient of any or all of the Collateral so disposed of at any public sale (or, to the extent permitted by law, at any private sale) and thereafter hold the same absolutely, free from any claim or right of whatsoever kind, including any right or equity of redemption (statutory or otherwise), of the Grantor, any such demand, notice and right or equity being hereby expressly waived and released. In the event of any sale, assignment, or other disposition of any of the Collateral consisting of Trademarks, the goodwill connected with and symbolized by the Trademarks subject to such disposition shall be included. The Lender may, without notice or publication, adjourn any public or private sale or cause the same to be adjourned from time to time by announcement at the time and place fixed for the sale, and such sale may be made at any time or place to which the sale may be so adjourned.

 

(vi)           The proceeds of each collection, sale or other disposition under this Section 4.05 , including by virtue of the exercise of any license granted to the Lender in Section 4.04 (a) , shall be applied in accordance with Section 4.09 .

 

(b)            Notice . The Grantor agree that to the extent the Lender is required by applicable law to give reasonable prior notice of any sale or other disposition of any Collateral, ten business days’ notice shall be deemed to constitute reasonable prior notice.

 

(c)             No Assumption of Obligations . Notwithstanding any provision in this Agreement or any other Loan Document to the contrary, the Secured Party is not assuming any liability or obligation of the Grantor or any of its Affiliates of whatever nature, whether presently in existence or arising or asserted hereafter. All such liabilities and obligations shall be retained by and remain obligations and liabilities of the Grantor and/or its Affiliates, as the case may be. Without limiting the foregoing, the Secured Party is not assuming and shall not be responsible for any liabilities or Claims of the Grantor or its Affiliates, whether present or future, absolute or contingent and whether or not relating to the Grantor, the Intellectual Property, and/or the Material Agreements, and the Grantor shall indemnify and save harmless the Secured Party from and against all such liabilities, Claims and Liens.

 

4.06         Deficiency . If the proceeds of sale, collection or other realization of or upon the Collateral pursuant to Section 4.05 are insufficient to cover the costs and expenses of such realization and the indefeasible payment in full in cash of the Secured Obligations (other than contingent indemnification obligations for which no claim has been made), the Grantor shall remain liable for any deficiency.

 

4.07         Locations; Names, Etc . The Grantor shall not (i) change its location or (ii) change its name from the name shown, or (iii) agree to or authorize any modification of the terms of any item of Collateral that, to the extent applicable, would result in a change of classification thereof from one category to another such category (such as from a general intangible to investment property), if the effect thereof would be to result in a loss of perfection of, or diminution of priority for, the security interests created hereunder in such item of Collateral, or the loss of control over such item of Collateral, unless in each case 30 (thirty) days’ prior written notice has been provided to the Lender and such change is not otherwise restricted by the terms of any Loan Document. To the extent applicable, the Grantor shall not store its Collateral with an aggregate value in excess of Euro 10,000 at any time with a bailee, consignee, or similar party, except for such bailees, consignees and similar parties as are disclosed on Annex I, unless in each case 30 days’ prior written notice has been provided to the Secured Party.

 

12
 

 

4.08         Private Sale . The Secured Party shall incur no liability as a result of the sale of the Collateral, or any part thereof, at any private sale pursuant to Section 4.05 conducted in a commercially reasonable manner. The Grantor hereby waives any claims against the Lender arising by reason of the fact that the price at which the Collateral may have been sold at such a private sale was less than the price that might have been obtained at a public sale or was less than the aggregate amount of the Secured Obligations, even if the Lender accepts the first offer received and does not offer the Collateral to more than one offeree.

 

4.09         Application of Proceeds . Except as otherwise herein expressly provided and except as provided below in this Section 4.09 , the proceeds of any collection, sale or other realization of all or any part of the Collateral pursuant hereto, and any other cash at the time held by the Lender under this Section 4 , shall be applied by the Lender (as the case may be):

 

First, to the payment of the costs and expenses of such collection, sale or other realization, including reasonable out of pocket costs and expenses of the Secured Party and the fees and expenses of their agents and counsel, and all expenses incurred and advances made by the Secured Party in connection therewith;

 

Next, to the indefeasible payment in full of the Secured Obligations (other than contingent indemnification obligations for which no claim has been made) in such order as the Lender in its sole discretion shall determine; and

 

Finally, to the payment to the Grantor, or its successors or assigns or as a court of competent jurisdiction may direct, of any surplus then remaining.

 

4.10         Attorney in Fact . Without limiting any rights or powers granted by this Agreement to the Secured Party, upon the occurrence of an Event of Default that has not been waived in writing by the Lender in accordance with the Loan Agreement, the Lender (and any of its officers, employees or agents) hereby is appointed the attorney in fact of the Grantor for the purpose of carrying out the provisions of this Section 4 and taking any action and executing any instruments that the Lender may deem necessary or advisable to accomplish the purposes hereof, which appointment as attorney in fact is irrevocable and coupled with an interest. Without limiting the generality of the foregoing, so long as the Lender shall be entitled under this Section 4 to make collections in respect of the Collateral, the Lender shall have the right and power to receive, endorse and collect all checks made payable to the order of the Grantor representing any dividend, payment or other distribution in respect of the Collateral or any part thereof and to give full discharge for the same.

 

13
 

 

4.11         Perfection and Recordation . The Grantor authorizes the Secured Party to file any and all statements, affidavits, certificates, extracts or similar instruments describing the Collateral as “all assets” or “all personal property and fixtures” of the Grantor (provided that no such description shall be deemed to modify the description of Collateral set forth in Section 3 ).

 

4.12         Termination . When all Secured Obligations (other than contingent indemnification obligations for which no claim has been made) shall have been indefeasibly paid in full in cash, this Agreement automatically shall terminate, and the Secured Party shall, upon request of the Grantor, cause to be assigned, transferred and delivered, against receipt but without any recourse, warranty or representation whatsoever, any remaining Collateral and money received in respect thereof, to or on the order of the Grantor and to be released and canceled all licenses and rights referred to in Section 4.04(a) , in each case, at Grantors’ sole expense. The Secured Party shall also, at the expense of the Grantor, execute and deliver to the Grantor upon such termination such termination statements, affidavits, certificates, notices, extracts or similar instruments for terminating the liens and such other documentation as shall be reasonably requested by the Grantor to effect the termination and release of the liens on the Collateral as required by this Section 4.12 , in each case, at Grantors’ sole expense.

 

4.13         Further Assurances . The Grantor agrees that, from time to time upon the written request of the Secured Party, the Grantor will execute and deliver such further documents and do such other acts and things as the Secured Party may request in order fully to effect the purposes of this Agreement and take all further action that may be required under applicable law (including the laws of each jurisdiction in which the Grantor or any of its Subsidiaries is organized), or that the Secured Party may reasonable request, in order to grant, preserve, protect and perfect the validity and priority of the Liens created or intended to be created by the Loan Documents. The Grantor will promptly cause any subsequently acquired or organized Subsidiary to take such action as shall be necessary and enter into such other security agreements and take such other actions as may be required or reasonably requested by the Lender to have a valid first priority Lien on and security interest in all of the assets of such Subsidiary. In addition, from time to time, the Grantor will, at its cost and expense, promptly secure the Secured Obligations by pledging or creating, or causing to be pledged or created, perfected Liens with respect to such of its assets and properties as the Secured Party shall designate, it being agreed that it is the intent of the parties that the Secured Obligations shall be secured by, among other things, substantially the assets of the Grantor (including Collateral acquired subsequent to the Closing Date). Such Liens will be created under the Loan Documents in form and substance satisfactory to the Secured Party and the Grantor shall deliver or cause to be delivered to the Secured Party all such instruments and documents as the Secured Party shall reasonably request to evidence compliance with this Section 4.13 . The Secured Party shall release any lien covering any asset that has been disposed of in accordance with the provisions of the Loan Documents.

 

Section 5.             Miscellaneous .

 

5.01         Notices . All notices, requests, instructions, directions and other communications provided for herein (including any modifications of, or waivers, requests or consents under, this Agreement) shall be given or made in writing (including by telecopy) delivered, if to Borrower, or any Lender, to its address specified on the second page hereto, or at such other address as shall be designated by such party in a notice to the other parties. Except as otherwise provided in this Agreement, all such communications shall be deemed to have been duly given upon receipt of a legible copy thereof, in each case given or addressed as aforesaid. All such communications provided for herein by telecopy shall be confirmed in writing promptly after the delivery of such communication (it being understood that non-receipt of written confirmation of such communication shall not invalidate such communication).

 

14
 

 

5.02         No Waiver . No failure on the part of the Secured Party to exercise, and no course of dealing with respect to, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise by the Secured Party of any right, power or remedy hereunder preclude any other or further exercise thereof or the exercise of any other right, power or remedy. The remedies herein are cumulative and are not exclusive of any remedies provided by law.

 

5.03         Amendments, Etc . The terms of this Agreement may be waived, altered or amended only by an instrument in writing duly executed by the Grantor and the Lender.

 

5.04         Expenses .

 

(a)             The Grantor shall pay or reimburse the Lender for costs and expenses in connection with or related to the Loan Agreement and this Agreement.

 

(b)            The Grantor shall hereby indemnify the Lender, its Affiliates, and their respective directors, officers, employees, attorneys, agents, advisors and controlling parties (each, an “ Indemnified Party ”) from and against, and agrees to hold them harmless against, any and all claims and losses of any kind (including reasonable fees and disbursements of counsel), joint or several, that may be incurred by or asserted or awarded against any Indemnified Party, in each case arising out of or in connection with or relating this Agreement or any of the other Loan Documents or the transactions contemplated hereby or thereby or any use made or proposed to be made with the proceeds of the Loans, whether or not any Indemnified Party is a party to an actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based in contract, tort or any other theory, and whether or not such investigation, litigation or proceeding is brought by Grantor, any of its shareholders, Subsidiaries, Affiliates or creditors, except to the extent such claim or loss is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s gross negligence or willful misconduct. No obligor shall assert any claim against any Indemnified Party, on any theory of liability, for consequential, indirect, special or punitive damages arising out of or otherwise relating to this Agreement or any of the other Loan Documents or any of the transactions contemplated hereby or thereby or the actual or proposed use of the proceeds of the Loans. The Lender shall not assert any claim against the Borrower, on any theory of liability, for consequential, indirect, special or punitive damages arising out of or otherwise relating to this Agreement or any of the other Loan Documents or any of the transactions contemplated hereby or thereby or the actual or proposed use of the proceeds of the Loans.

 

5.05         Successors and Assigns . This Agreement shall be binding upon and inure to the benefit of the respective successors and assigns of the Grantor and the Lender (provided that the Grantor shall not assign or transfer its rights or obligations hereunder unless consented to in writing by the Lender in accordance with the Loan Agreement).

 

15
 

 

5.06         Counterparts . This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this Agreement by signing any such counterpart.

 

5.07         Governing Law; Submission to Jurisdiction; Etc .

 

(a) Governing Law . This Agreement and the rights and obligations of the parties hereunder shall be governed by, and construed in accordance with, the law of the Grand Duchy of Luxembourg, without regard to principles of conflicts of laws that would result in the application of the laws of any other jurisdiction.

 

(b)            Submission to Jurisdiction . The Grantor agree that any suit, action or proceeding with respect to this Agreement or any other Loan Document to which it is a party or any judgment entered by any court in respect thereof may be brought initially in the courts of the Grand Duchy of Luxembourg or in the courts of its own corporate domicile and irrevocably submits to the non-exclusive jurisdiction of each such court for the purpose of any such suit, action, proceeding or judgment. This Section 5.07(b) is for the benefit of the Lender only and, as a result, the Lender shall not be prevented from taking proceedings in any other courts with jurisdiction. To the extent allowed by applicable Laws, the Secured Party may take concurrent proceedings in any number of jurisdictions.

 

(c)             Waiver of Venue . The Grantor irrevocably waives to the fullest extent permitted by law any objection that it may now or hereafter have to the laying of the venue of any suit, action or proceeding arising out of or relating to this Agreement and hereby further irrevocably waives to the fullest extent permitted by law any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. A final judgment (in respect of which time for all appeals has elapsed) in any such suit, action or proceeding shall be conclusive and may be enforced in any court to the jurisdiction of which the Grantor is or may be subject, by suit upon judgment.

 

(d)            Service of Process . Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 5.01 . Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law.

 

5.08         Captions . The captions and section headings appearing herein are included solely for convenience of reference and are not intended to affect the interpretation of any provision of this Agreement.

 

5.09         Agents and Attorneys in Fact . The Lender may employ agents and attorneys in fact in connection herewith and shall not be responsible for the negligence or misconduct of any such agents or attorneys in fact selected by it in good faith.

 

16
 

 

5.10         Severability . If any provision hereof is invalid and unenforceable in any jurisdiction, then, to the fullest extent permitted by law, (a) the other provisions hereof shall remain in full force and effect in such jurisdiction and shall be liberally construed in favor of the Secured Party in order to carry out the intentions of the parties hereto as nearly as may be possible and (b) the invalidity or unenforceability of any provision hereof in any jurisdiction shall not affect the validity or enforceability of such provision in any other jurisdiction.

 

 

 

 

the remainder intentionally left blank – signature pages to follow

 

17
 

 

IN WITNESS WHEREOF, the parties hereto have caused this Security Agreement to be duly executed and delivered as of the day and year first above written.

 

 

 

Nexeon Medsystems Belgium S.p.r.l. ,

as Grantor

       
       
  By: /s/ William Rosellini  
  Name: William Rosellini  
  Title: CEO  

 

 

 

Nexeon Medsystems Europe, S.à r.l. ,

as Lender and Secured Party

     
     
By: /s/ William Rosellini  
Name: William Rosellini  
Title: CEO  

 

 

 

18